Chiung-Mei Chen

Title: Innovations of Chiung-Mei Chen

Introduction

Chiung-Mei Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of neurodegenerative disorders through his innovative research and patented methods. With a total of 2 patents, his work focuses on treating conditions such as spinocerebellar ataxias.

Latest Patents

Chiung-Mei Chen's latest patents include a method for treating spinocerebellar ataxias. This invention involves administering a pharmaceutical composition that reduces the production of reactive oxygen species and inflammatory factors, thereby suppressing polyglutamine aggregation. Another significant patent is a method for inhibiting neuronal cell aggregation, which utilizes the Chinese herb treatment for neurodegenerative disorders. This method specifically targets polyQ-mediated spinocerebellar ataxia using ammonium glycyrrhizinate and licochalcone A.

Career Highlights

Chiung-Mei Chen is affiliated with National Taiwan Normal University, where he conducts his research and develops his innovative methods. His work has garnered attention in the scientific community for its potential impact on treating neurodegenerative diseases.

Collaborations

Chiung-Mei Chen collaborates with Guey-Jen Lee-Chen, who is also involved in research related to neurodegenerative disorders. Their partnership enhances the scope and depth of their innovative projects.

Conclusion

Chiung-Mei Chen's contributions to the field of neurodegenerative disorders through his patents demonstrate his commitment to advancing medical science. His innovative methods hold promise for improving treatment options for patients suffering from these challenging conditions.